SEMABIZ, Inc. | ChosaReport.com

日本と海外の市場調査レポート＆サービスを取り扱っております。

体外診断用医薬品の技術と世界市場

In Vitro Diagnostics: Technologies and Global Markets

体外診断用医薬品の技術と世界市場

商品番号 : SMB-72177

出版社BCC Research
出版年月2025年1月
ページ数159
価格タイプシングルユーザライセンス
価格USD 4,650
種別英文調査報告書

Report Highlights

The global market for In Vitro Diagnostics (IVD) is expected to grow from $94.7 billion in 2024 and is projected to reach $141.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.

体外診断用医薬品 (IVD) の世界市場は、2024 年の 947 億ドルから成長し、2024 -2029年までの予測期間中に 8.4% の年間平均成長率 (CAGR) で、2029 年末までに 1,419 億ドルに達すると予測されています。

Report Scope

This report covers the in vitro diagnostic (IVD) technologies as well as in vitro diagnostic devices used in hospitals and point-of-care (POC) facilities to diagnose diseases. It also details the current and future market potential of in vitro diagnostic technology and includes an analysis of this market’s competitive environment. The report covers market drivers, restraints, opportunities, product approvals, regulatory scenario assessments and emerging technologies. It features market projections and estimates of the market shares of key players through 2029.

In this analysis, the in vitro diagnostics market is segmented based on technologies, applications, end users and region. Based on technologies, the market is segmented into the following categories: hematology, immunochemistry, molecular diagnostics, POC testing, clinical microbiology and tissue diagnostics. Based on applications, the in vitro diagnostics market is segmented into these categories: diabetes, nephrology, blood glucose evaluation and monitoring (BGEM), oncology, cardiology, infectious diseases and other applications. The market is segmented based on end users into diagnostic laboratories, hospitals and clinics, point-of-care centers, and other end users.

The global in vitro diagnostics market has been segmented by the following geographical regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The report features detailed analyses of major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Australia and New Zealand (ANZ), Argentina, Brazil, South Africa, Mexico and the GCC countries. Market analysis data is provided for 2023, which serves as the base year, and estimates are given for 2024 and forecast values through 2029.

Report Synopsis

Report MetricsDetails
Base year considered2023
Forecast period considered2024-2029
Base year market size$87.8 billion
Market size forecast$141.9 billion
Growth rateCAGR of 8.4% for the forecast period of 2024-2029
Units considered$ Millions
Segments coveredTechnology, Product, Application, End Users, and Region
Regions coveredNorth America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Countries coveredU.S., Canada, Mexico, China, Japan, India, Australia and New Zealand, Germany, Italy, France, U.K., Spain, Brazil, Argentina, and South Africa
Key Market Drivers
  • Rise in the population of older adults and dependency on frequent diagnosis procedures.
  • Integration of artificial intelligence in In Vitro Diagnostics.
  • Rising incidence of chronic diseases.
  • Improving the quality of point-of-care testing.
Companies studied
ABBOTTBD
BIOMERIEUXBIO-RAD LABORATORIES INC.
BIO-TECHNEBRUKER
DANAHER CORP.EKF DIAGNOSTICS HOLDINGS PLC
F. HOFFMANN-LA ROCHE LTD.HOLOGIC INC.
JSR CORP.QUIDELORTHO CORP.
SIEMENS HEATHNIEERS AGSYSMEX CORP.
THERMO FISHER SCIENTIFIC INC.

Report Includes

– 41 data tables and 54 additional tables

– Analysis of global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029

– Estimates of the size of the market for in vitro diagnostics (IVD) technologies, revenues, and market shares by technology, product, application, end user and region

– Assessment of market dynamics such as drivers, restraints and opportunities

– Discussion of how the rise in the number of respiratory infections, hospital acquired infections (HAIs), and sexually transmitted diseases are creating a constant need for IVD testing in hospitals and laboratories

– Discussion of IVD for neglected infectious diseases, chemistry-based portable analysis and microfluidic platform-based POC tests

– A discussion on ESG challenges and practices in the industry

– Assessment of the competitive landscape, including the market shares of key companies, their product portfolios and financial overviews

– Information on recent mergers, acquisitions, expansions, collaborations, investments, divestments and product launches

– Profiles of the leading companies, including F. Hoffmann-La Roche Ltd., Abbott, Sysmex Corp., Danaher, BD, and Siemens Healthineers AG。

Table of Contents

Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market and Technology Background
Introduction
In vitro Diagnostics Technology
Overview
Classification of In Vitro Diagnostic Elements
Importance of In Vitro Diagnostics Technologies and Quality Control
Difference Between In Vitro and In Vivo Diagnostics
Regulations in the IVD Industry
Regulation of IVD Products in Different Countries
Chapter 3 Market Dynamics
Overview
Market Drivers
Rise in Population of Older Adults: Dependence on Diagnosis Procedures
Integration of Artificial Intelligence in Vitro Diagnostics
Rising Prevalence of Chronic Diseases
Improving the Quality of Point-of-Care Testing (POCT)
Market Restraints
Challenges Associated with Technologies Product Packaging
Increases in Shipping Costs or Service Issues
Laboratory Assistant’s Inability to Handle Laboratory Equipment and Consumables
Market Opportunities
Rise in Home Care Testing Devices
Demand for Point-of-Care (POC) Testing Units
Growing Demand for AI and the Internet of Things
Chapter 4 Emerging Technologies and Developments
Emerging Technologies in the IVD Market
Artificial Intelligence
Modified Old IVD Techniques
Liquid Biopsy
Automated In Vitro Diagnostic Devices
Emerging Developments in In Vitro Diagnostics
FDA Approval
Rise in Demand for Personalized Medicine
Lab Automation and Digital Health Platform
Portability Option in IVD Devices
Home Care Kits for Cancer Diagnosis
FDA Approved In Vitro Diagnostic Devices: AI Enabled
Chapter 5 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis by Technology
Immunochemistry
POC Testing
Hematology
Molecular Diagnostics
Tissue Diagnostics
Clinical Microbiology
Market Analysis by Application
Diabetes
Nephrology
Blood Glucose Evaluation and Monitoring (BGEM)
Oncology
Cardiology
Infectious Diseases
Other Applications
Market Analysis by End User
Diagnostic Laboratory
Hospitals and Clinics
Point-of-Care (POC) Centers
Other End Users
Geographical Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
Chapter 6 Competitive Intelligence
Introduction
Global Analysis of Company Market Ranking
Glimpse of Leading In Vitro Diagnostics (IVD) Companies in China
Agreements, Collaborations and Partnerships
bioMérieux Agreements
Siemens Healthineers and Sysmex Enter into a Global Agreement
Roche Enters into Agreement with Path AI
Quidel Corp. Signs Agreement to Acquire Ortho Clinical Diagnostics
In Vitro Diagnostics Companies and Start-Ups in 2021-2023
Diagopreutic Private Limited
Diatherax
IPLEXMED
Magnify Bioscience Inc.
Chapter 7 Sustainability in the In Vitro Diagnostics Industry: An ESG Perspective
Importance of ESG in In Vitro Diagnostics Manufacturing Industry
ESG Practices in the In Vitro Diagnostics Industry
Environmental Performance
Social Performance
Governance Performance
Company Role in ESG Development
ESG Risk Ratings
BCC Research Viewpoint
Chapter 8 Appendix
Research Methodology
References
Company Profiles
ABBOTT
BD
BIOMERIEUX
BIO-RAD LABORATORIES INC.
BIO-TECHNE
BRUKER
DANAHER CORP.
EKF DIAGNOSTICS HOLDINGS PLC
F. HOFFMANN-LA ROCHE LTD.
HOLOGIC INC.
JSR CORP.
QUIDELORTHO CORP.
SIEMENS HEATHNIEERS AG
SYSMEX CORP.
THERMO FISHER SCIENTIFIC INC.

List of Tables

Summary Table : Global Market for In Vitro Diagnostics, by Technology, Through 2029

Table 1 : Approved FDA In Vitro Diagnostics Devices, 2021–2024

Table 2 : Differences Between In Vitro and In Vivo Diagnostics

Table 3 : FDA Approval of Artificial Intelligence and Machine Learning–Enabled Medical Devices, 2024

Table 4 : Global Market for In Vitro Diagnostics, by Technology, Through 2029

Table 5 : Global Market for In Vitro Diagnostics in Immunochemistry, by Region, Through 2029

Table 6 : Global Market for In Vitro Diagnostics in POC Testing, by Region, Through 2029

Table 7 : Summary of Electrochemiluminescence POCT Devices with Their Analytic Performance

Table 8 : Global Market for In Vitro Diagnostics in Hematology, by Region, Through 2029

Table 9 : Global Market for In Vitro Diagnostics in Molecular Diagnostics, by Region, Through 2029

Table 10 : Global Market for In Vitro Diagnostics in Tissue Diagnostics, by Region, Through 2029

Table 11 : Global Market for In Vitro Diagnostics in Clinical Microbiology, by Region, Through 2029

Table 12 : Global Market for In Vitro Diagnostics, by Application, Through 2029

Table 13 : Global Market for Diabetes in In Vitro Diagnostics, by Region, Through 2029

Table 14 : Global Market for Nephrology in In Vitro Diagnostics, by Region, Through 2029

Table 15 : Global Market for BGEM in In Vitro Diagnostics, by Region, Through 2029

Table 16 : Global Market for Oncology in In Vitro Diagnostics, by Region, Through 2029

Table 17 : Global Market for Cardiology in In Vitro Diagnostics, by Region, Through 2029

Table 18 : Global Market for Infectious Diseases in In Vitro Diagnostics, by Region, Through 2029

Table 19 : Global Market for Other Applications in In Vitro Diagnostics, by Region, Through 2029

Table 20 : Global Market for In Vitro Diagnostics, by End User, Through 2029

Table 21 : Global Market for In Vitro Diagnostics for Diagnostic Laboratory, by Region, Through 2029

Table 22 : Global Market for In Vitro Diagnostics for Hospitals and Clinics, by Region, Through 2029

Table 23 : Global Market for In Vitro Diagnostics for Point-of-Care Centers, by Region, Through 2029

Table 24 : Global Market for In Vitro Diagnostics for Other End Users, by Region, Through 2029

Table 25 : Global Market for In Vitro Diagnostics, by Region, Through 2029

Table 26 : North American Market for In Vitro Diagnostics, by Country, Through 2029

Table 27 : European Market for In Vitro Diagnostics, by Country, Through 2029

Table 28 : Asia-Pacific Market for In Vitro Diagnostics, by Country, Through 2029

Table 29 : Latin American Market for In Vitro Diagnostics, by Sub-Region, Through 2029

Table 30 : Total Imports of Medical Equipment into Brazil, 2021 and 2022

Table 31 : Middle Eastern and African Market for In Vitro Diagnostics Technology, by Sub-Region, Through 2029

Table 32 : bioMérieux Agreements

Table 33 : ESG Practices: Environmental Performance

Table 34 : ESG Practices: Social Performance

Table 35 : ESG Practices: Governance Performance

Table 36 : Creating an Attractive Workplace: Social Performance

Table 37 : ESG Rankings for Leading In Vitro Diagnostics Companies, 2023 and 2024*

Table 38 : Abbott: Company Snapshot

Table 39 : Abbott: Financial Performance, FY 2022 and 2023

Table 40 : Abbott: Product Portfolio

Table 41 : Abbott: News/Key Developments, 2022-2024

Table 42 : BD: Company Snapshot

Table 43 : BD: Financial Performance, FY 2022 and 2023

Table 44 : BD: Product Portfolio

Table 45 : BD: News/Key Developments, 2022-2024

Table 46 : BIOMÉRIEUX: Company Snapshot

Table 47 : BIOMÉRIEUX: Financial Performance, FY 2022 and 2023

Table 48 : BIOMÉRIEUX: Product Portfolio

Table 49 : BIOMÉRIEUX: News/Key Developments, 2023 and 2024

Table 50 : Bio-Rad Laboratories Inc.: Company Snapshot

Table 51 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023

Table 52 : Bio-Rad Laboratories Inc.: Product Portfolio

Table 53 : Bio-Rad Laboratories Inc.: News/Key Developments, 2021-2024

Table 54 : Bio-Techne: Company Snapshot

Table 55 : Bio-Techne: Financial Performance, FY 2022 and 2023

Table 56 : Bio-Techne: Product Portfolio

Table 57 : Bio-Techne: News/Key Developments, 2022 and 2023

Table 58 : Bruker: Company Snapshot

Table 59 : Bruker: Financial Performance, FY 2022 and 2023

Table 60 : Bruker: Product Portfolio

Table 61 : Bruker: News/Key Developments, 2021-2024

Table 62 : Danaher Corp.: Company Snapshot

Table 63 : Danaher Corp.: Financial Performance, FY 2022 and 2023

Table 64 : Danaher Corp.: Product Portfolio

Table 65 : Danaher Corp.: News/Key Developments, 2021-2023

Table 66 : EKF Diagnostics Holdings plc.: Company Snapshot

Table 67 : EKF Diagnostics Holdings plc.: Financial Performance, FY 2022 and 2023

Table 68 : EKF Diagnostics Holdings plc.: Product Portfolio

Table 69 : EKF Diagnostics Holdings plc.: News/Key Developments, 2022-2024

Table 70 : F. Hoffmann-La Roche Ltd.: Company Snapshot

Table 71 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023

Table 72 : F. Hoffmann-La Roche Ltd.: Product Portfolio

Table 73 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2022-2024

Table 74 : Hologic Inc.: Company Snapshot

Table 75 : Hologic Inc.: Financial Performance, FY 2022 and 2023

Table 76 : Hologic Inc.: Product Portfolio

Table 77 : Hologic Inc.: News/Key Developments, 2022-2024

Table 78 : JSR Corp.: Company Snapshot

Table 79 : JSR Corp.: Financial Performance, FY 2022 and 2023

Table 80 : JSR Corp.: Product Portfolio

Table 81 : JSR Corp.: News/Key Developments, 2024

Table 82 : QuidelOrtho Corp.: Company Snapshot

Table 83 : QuidelOrtho Corp.: Financial Performance, FY 2022 and 2023

Table 84 : QuidelOrtho Corp.: Product Portfolio

Table 85 : QuidelOrtho Corp.: News/Key Developments, 2021-2024

Table 86 : Siemens Healthineers AG: Company Snapshot

Table 87 : Siemens Healthineers AG: Financial Performance, FY 2022 and 2023

Table 88 : Siemens Healthineers AG: Product Portfolio

Table 89 : Siemens Healthineers AG: News/Key Developments, 2021-2024

Table 90 : Sysmex Corp.: Company Snapshot

Table 91 : Sysmex Corp.: Financial Performance, FY 2022 and 2023

Table 92 : Sysmex Corp.: Product Portfolio

Table 93 : Sysmex Corp.: News/Key Developments, 2022 and 2023

Table 94 : Thermo Fisher Scientific Inc.: Company Snapshot

Table 95 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023

Table 96 : Thermo Fisher Scientific Inc.: Product Portfolio

Table 97 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022 and 2023

List of Figures

Summary Figure : Global Market Shares of In Vitro Diagnostics, by Technology, 2023

Figure 1 : Snapshot of Market Dynamics

Figure 2 : Older Adults Using Technology to Manage Chronic Health Issues in the U.S., by Age Group, 2024

Figure 3 : Percentage of People Aged 50+ Using Digital Services in the U.S., 2024

Figure 4 : Breakdown of Global Elderly Population (Aged 65+ Years), by Select Countries, 2022

Figure 5 : Emerging AI Applications in In Vitro Diagnostics

Figure 6 : Global Market Shares of In Vitro Diagnostics, by Technology, 2023

Figure 7 : Global Market Shares of In Vitro Diagnostics, by Application, 2023

Figure 8 : Snapshot of IVD Tests in Oncology

Figure 9 : Global Market Shares of In Vitro Diagnostics, by End User, 2023

Figure 10 : Global Market Shares of In Vitro Diagnostics, by Region, 2023

Figure 11 : North American Market Shares of In Vitro Diagnostics, by Technology, 2023

Figure 12 : North American Market Shares of In Vitro Diagnostics, by Application, 2023

Figure 13 : North American Market Shares of In Vitro Diagnostics, by End User, 2023

Figure 14 : North American Market Shares of In Vitro Diagnostics, by Country, 2023

Figure 15 : European Market Shares of In Vitro Diagnostics, by Technology, 2023

Figure 16 : European Market Shares of In Vitro Diagnostics, by Application, 2023

Figure 17 : European Market Shares of In Vitro Diagnostics, by End User, 2023

Figure 18 : European Market Shares of In Vitro Diagnostics, by Sub-Region , 2023

Figure 19 : Asia-Pacific Market Shares of In Vitro Diagnostics, by Technology, 2023

Figure 20 : Asia-Pacific Market Shares of In Vitro Diagnostics, by Application, 2023

Figure 21 : Asia-Pacific Market Shares of In Vitro Diagnostics, by End User, 2023

Figure 22 : Asia-Pacific Market Shares of In Vitro Diagnostics, by Country, 2023

Figure 23 : Latin American Market Shares of In Vitro Diagnostics, by Technology, 2023

Figure 24 : Latin American Market Shares of In Vitro Diagnostics, by Application, 2023

Figure 25 : Latin American Market Shares of In Vitro Diagnostics, by End User, 2023

Figure 26 : Latin American Market Shares of In Vitro Diagnostics, by Sub-Region, 2023

Figure 27 : Middle Eastern and African Market Shares of In Vitro Diagnostics, by Technology, 2023

Figure 28 : Middle Eastern and African Market Shares of In Vitro Diagnostics, by Application, 2023

Figure 29 : Middle Eastern and African Market Shares of In Vitro Diagnostics, by End User, 2023

Figure 30 : Middle Eastern and African Market Shares of In Vitro Diagnostics, by Sub-Region, 2023

Figure 31 : Rankings of Leading Companies in Global In Vitro Diagnostics Market, 2023

Figure 32 : Snapshot: Key ESG Trends in the In Vitro Diagnostics Industry

Figure 33 : Abbott: Revenue Shares, by Business Unit, FY 2023

Figure 34 : Abbott: Revenue Shares, by Country/Region, FY 2023

Figure 35 : BD: Revenue Shares, by Business Unit, FY 2023

Figure 36 : BD: Revenue Shares, by Country/Region, FY 2023

Figure 37 : BIOMÉRIEUX: Revenue Shares, by Business Unit, FY 2023

Figure 38 : BIOMÉRIEUX: Revenue Shares, by Country/Region, FY 2023

Figure 39 : Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2023

Figure 40 : Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2023

Figure 41 : Bio-Techne: Revenue Shares, by Business Unit, FY 2023

Figure 42 : Bio-Techne: Revenue Shares, by Country/Region, FY 2023

Figure 43 : Bruker: Revenue Shares, by Business Unit, FY 2023

Figure 44 : Bruker: Revenue Shares, by Country/Region, FY 2023

Figure 45 : Danaher Corp.: Revenue Shares, by Business Unit, FY 2023

Figure 46 : Danaher Corp.: Revenue Shares, by Country/Region, FY 2023

Figure 47 : EKF Diagnostics Holdings plc.: Revenue Shares, by Business Unit, FY 2023

Figure 48 : EKF Diagnostics Holdings plc.: Revenue Shares, by Country/Region, FY 2023

Figure 49 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Business Unit, FY 2023

Figure 50 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Country/Region, FY 2023

Figure 51 : Hologic Inc.: Revenue Shares, by Business Unit, FY 2023

Figure 52 : Hologic Inc.: Revenue Shares, by Country/Region, FY 2023

Figure 53 : JSR Corp.: Revenue Shares, by Business Unit, FY 2023

Figure 54 : JSR Corp.: Revenue Shares, by Country/Region, FY 2023

Figure 55 : QuidelOrtho Corp.: Revenue Shares, by Business Unit, FY 2023

Figure 56 : QuidelOrtho Corp.: Revenue Shares, by Country/Region, FY 2023

Figure 57 : Siemens Healthineers AG: Revenue Shares, by Business Unit, FY 2023

Figure 58 : Siemens Healthineers AG: Revenue Shares, by Country/Region, FY 2023

Figure 59 : Sysmex Corp.: Revenue Shares, by Business Unit, FY 2023

Figure 60 : Sysmex Corp.: Revenue Shares, by Country/Region, FY 2023

Figure 61 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023

Figure 62 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023

医療・医薬の最新記事8件